[Morphologic and biochemical criteria of the efficacy of clinical use of phosphocreatine (neoton) for intraoperative protection of the myocardium].
D000328:Adult; D003327:Coronary Disease / Q000188:drug therapy*; D006324:Heart Arrest, Induced / Q000009:adverse effects*; D006350:Heart Valve Prosthesis; D006801:Humans; D007431:Intraoperative Complications / Q000188:drug therapy; D008875:Middle Aged; D010725:Phosphocreatine / Q000627:therapeutic use*
D010725:Phosphocreatine
Morfologicheskie i biokhimicheskie kriterii éffektivnosti klinicheskogo primeneniia fosfokreatina (neotona) pri intraoperatsionnoĭ zashchite miokarda.